These findings not only confirm that the activation of endothelin system may play a role in mediating relative LVH in breast cancer patients but also indicate that big ET-1 is a sensitive biomarker that may help clinicians identify patients at higher risk for subsequent cardiac remodelling. The gene discussed is EDN1; the disease is breast carcinoma.